Sun Nelson
- SEC CIK
- 0002045377
Latest role at each company
- AARD Aardvark Therapeutics, Inc.See Remarksas of Sep 11, 2026
Trades
Every Form 4 that lists Sun Nelson as a reporting owner, including filings made jointly with others. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Company | Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| AARDAardvark Therapeutics, Inc. | Sep 11, 20268:14 PM ET | Sep 10 – Sep 11, 2026 | Sun NelsonSee Remarks | SSaleCommon Stock, par value $0.00001 per share | −76.75K | $5.1458 | −$394.96K | 35.48K | −68.4% | SEC10b5-1 |
| AARDAardvark Therapeutics, Inc. | Dec 12, 2025 | Dec 11, 2025 | Sun NelsonChief Financial Officer | PPurchaseCommon Stock | +3K | $14.40 | +$43.2K | 108.48K | +2.8% | SEC |
| AARDAardvark Therapeutics, Inc. | Sep 10, 2025 | Sep 9, 2025 | Sun NelsonChief Financial Officer | PPurchaseCommon Stock | +6K | $8.07 | +$48.42K | 105.48K | +6.0% | SEC |
| AARDAardvark Therapeutics, Inc. | Feb 19, 2025 | Feb 14, 2025 | Sun NelsonChief Financial Officer | PPurchaseCommon Stock | +10K | $16.00 | +$160K | 99.48K | +11.2% | SEC |